Advertisement

Reactions Weekly

, Volume 1753, Issue 1, pp 197–197 | Cite as

Infliximab

Various toxicities: 9 case reports
Case report
  • 4 Downloads

Reference

  1. Riller Q, et al. Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment. Journal of Neurology 266: 1073-1078, No. 5, May 2019. Available from: URL: http://doi.org/10.1007/s00415-019-09234-y - France

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations